Shandong Xinke Biological Technology Co. Ltd is specialized in research, production, sales, and business as integrated into high-tech and share ownership enterprises. The company has owned completed technology research center, production base, and marketing center, which has developed into High-New-Tech enterprise with international leading specimen preparation and microbiological identification, it is one unique and large-size integrated company that their productions are covering full- automatic blood bacterial culture apparatus, and microbiological identification & drug sensitivity analysis system with other biochemical reagent, Antigen-antibody preparation. The company has been granted with High-New-Tech enterprise by Shandong Technology Administration since 2004. From 2006, Xinke has engaged project that is biological vaccine and high-tech industrialized of diagnostic reagent sponsored by National Development and Reform Committee. In 2008, it was supported by the national technology innovation funds, so responsible for project of the national torch plan`s industrialized, cooperated projects with Microbiological Epidemic Research Institute Of Military Academy Of Medical Science, Shanghai Institute of Optics And Fine Mechanics Chinese Academy of Sciences, National Institute for Communicable Disease Control and Prevention, which are the national epidemic special projects. It has obtained tens invention and practical patents in medical equipment, fast diagnosis, biological chips, treatment reagent. It has participated in the initiated ceremony of the most important project in July 2010 that is sponsored by The National Science Technology Ministry, The Health Ministry, and the People&＃039;s Government of Chongqing Municipality. It has reached agreement with Urban and Countryside of Development Foundation of China in Aug 2010. Their products have listed with the national proper equipments for promotion by China Medical Equipment Association. In 2011, the company h